CAS 217500-96-4: Tulathromycin
Description:Tulathromycin is a macrolide antibiotic primarily used in veterinary medicine, particularly for treating respiratory infections in livestock. It is characterized by its broad-spectrum activity against various Gram-positive and some Gram-negative bacteria, making it effective against pathogens such as Mycoplasma and Pasteurella species. The compound features a unique structure that includes a large lactone ring, which is typical of macrolides, contributing to its mechanism of action by inhibiting bacterial protein synthesis. Tulathromycin is administered via injection and has a prolonged half-life, allowing for extended therapeutic effects with fewer doses. Its pharmacokinetics are favorable for use in animals, as it achieves high tissue concentrations, particularly in the lungs, which is beneficial for treating respiratory diseases. Additionally, tulathromycin is known for its low toxicity profile in target species, although it is important to adhere to withdrawal times before slaughter to ensure food safety. Overall, tulathromycin represents a significant advancement in veterinary antibiotics, providing effective treatment options for common infections in livestock.
Formula:C41H79N3O12
InChI:InChI=1S/C41H79N3O12/c1-15-17-42-22-41(50)28(8)53-31(20-39(41,10)51-14)55-33-25(5)35(56-37-32(45)29(44(12)13)18-24(4)52-37)38(9,48)19-23(3)21-43-27(7)34(46)40(11,49)30(16-2)54-36(47)26(33)6/h23-35,37,42-43,45-46,48-50H,15-22H2,1-14H3/t23-,24-,25+,26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,37+,38-,39-,40-,41+/m1/s1
InChI key:InChIKey=GUARTUJKFNAVIK-QPTWMBCESA-N
SMILES:O=C1OC(CC)C(O)(C)C(O)C(NCC(C)CC(O)(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)C(OC3OC(C)C(O)(CNCCC)C(OC)(C)C3)C1C)C
- Synonyms:
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
- 1-Oxa-6-azacyclopentadecan-15-one, 13-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-
- Cp 472295
- Draxxin
- Increxxa
- Lydaxx
- Tulathromycin
- Tulaven
- Tulinovet
- See more synonyms
- Tulissin
- 1-Oxa-6-azacyclopentadecan-15-one, 13-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-
- Tulathromycin A